Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 600,000 shares at $14.58 ($8.6M) on 2021-07-16, disclosed to the SEC on 2021-07-20.
Open-market sale of $8.6M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.58 | 110,329 | $1.6M | 18.7% |
| 2 | $14.58 | 110,329 | $1.6M | 18.7% |
| 3 | $15.33 | 29,434 | $451K | 5.2% |
| 4 | $15.33 | 29,434 | $451K | 5.2% |
| 5 | $14.02 | 160,237 | $2.2M | 26.1% |
| 6 | $14.02 | 160,237 |
| $2.2M |
| 26.1% |
| Total | $14.35 avg | 600,000 | $8.6M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |